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Abstract 
Streptococcus uberis is a common cause of clinical and subclinical mastitis in dairy cattle. Several virulence mecha-
nisms have been proposed to contribute to the species’ ability to cause disease. Here, virulence characteristics were 
compared between S. uberis strains FSL Z1-048, which consistently caused clinical mastitis in a challenge model, and 
FSL Z1-124, which consistently failed to cause disease in the same model, to ascertain whether in vitro virulence 
characteristics were related to clinical outcome. Macrophages derived from bovine blood monocytes failed to kill FSL 
Z1-048 whilst reducing survival of FSL Z1-124 by 42.5%. Conversely, blood derived polymorphonuclear cells caused 
more reduction (67.1 vs. 44.2%, respectively) in the survival of FSL Z1-048 than in survival of FSL Z1-124. After 3 h 
of coincubation with bovine mammary epithelial cell line BME-UV1, 1000-fold higher adherence was observed for 
FSL Z1-048 compared to FSL Z1-124, despite presence of a frame shift mutation in the sua gene of FSL Z1-048 that 
resulted in predicted truncation of the S. uberis Adhesion Molecule (SUAM) protein. In contrast, FSL Z1-124 showed 
higher ability than FSL Z1-048 to invade BME-UV1 cells. Finally, observed biofilm formation by FSL Z1-124 was signifi-
cantly greater than for FSL Z1-048. In summary, for several hypothetical virulence characteristics, virulence phenotype 
in vitro did not match disease phenotype in vivo. Evasion of macrophage killing and adhesion to mammary epithelial 
cells were the only in vitro traits associated with virulence in vivo, making them attractive targets for further research 
into pathogenesis and control of S. uberis mastitis.
© 2015 Tassi et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Streptococcus uberis is one of the most common causes 
of clinical and subclinical mastitis in dairy cattle [1, 2]. 
Infections may be transient or chronic, associated with 
low or high somatic cell count (SCC), and limited to an 
individual animal or part of an outbreak affecting multi-
ple animals [3, 4]. In addition, S. uberis may be found in 
bovine faeces and in the farm environment [5, 6]. Based 
on whole genome analysis of the type strain O140J, S. 
uberis has been described as an opportunistic pathogen 
that utilises nutritional flexibility to adapt to a range of 
ecological niches, including the mammary gland [7]. 
Others, however, have proposed numerous virulence 
traits that may be associated with the ability of S. uberis 
to cause mastitis. Examples include production of 
antiphagocytic factors that affect interaction with mac-
rophages and neutrophils [1, 8], the ability to adhere to 
and invade into bovine mammary epithelial cells, poten-
tially mediated by the S. uberis adhesion molecule SUAM 
[9, 10], and the ability to form biofilm [11, 12].
Macrophages represent a major component of the 
cell population in the healthy lactating mammary gland 
and the first line of defense against pathogens [13–16]. 
Their general function is to phagocytise and kill patho-
gens. After intramammary challenge with S. uberis strain 
O140J, microscopic analysis demonstrated presence of the 
bacteria within the cytoplasm of mammary macrophages. 
This suggests that macrophages are capable of phagocyt-
ising S. uberis and may play a role in its clearance from 
the mammary gland, although actual killing of S. uberis 
O140J was not observed during in vitro experiments [17, 
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18]. Following the recognition of pathogens via pattern 
recognition receptors, mammary gland macrophages are 
involved in the initiation of the immune response. They 
produce proinflammatory cytokines such as TNF-α and 
interleukin (IL)-1β and chemokines such as IL-8, which 
contributes to migration of polymorphonuclear cells 
(PMN) from the blood stream to the mammary gland [14, 
19, 20]. The role of PMN is to ingest and kill the bacteria 
at the site of the infection. PMN are crucial in response 
to intramammary infection (IMI) caused by major mas-
titis pathogens such as Escherichia coli and Staphylo-
coccus aureus [20–22]. For S. uberis, the ability of PMN 
to kill different strains has been linked to strain-specific 
virulence. Hill [23] selected two strains with extreme dif-
ferences in susceptibility to killing by PMNs and showed 
that the strain that was most resistant to killing, S. uberis 
O140J, had a higher ability to cause clinical mastitis in 
lactating cows than S. uberis EF20, which was least resist-
ant to killing [23]. Separate challenge studies conducted 
with strain O140J [24] or strain UT888 [25] showed that 
massive influx of PMN into the mammary gland failed to 
control S. uberis infection. In contrast, a challenge study 
conducted with S. uberis U103 [26] showed that influx of 
PMN reduced the number of bacteria after an initial peak. 
Taken together, the observations are consistent with the 
idea that some strains are more resistant to PMN killing 
than others, and that this may contribute to differences in 
clinical manifestation of infections.
In addition to interaction with leucocytes, interaction 
with host epithelial cells plays a role in the pathogenesis 
of infection. Adhesion to and internalization into epi-
thelial cells are considered a crucial stage for the infec-
tion process in bacterial diseases because they allow the 
pathogen to target the appropriate tissue [27]. In the con-
text of the mastitis, adherence to mammary gland epi-
thelia would allow the bacteria to colonize the lactating 
mammary gland despite the flow of milk, which results 
in excretion of non-adherent bacteria [1]. Invasion of 
epithelial cells would prevent phagocytes from eliminat-
ing the bacteria and may be associated with spread of the 
infection to deeper tissues and development of persistent 
infections [2, 28]. Adhesion and invasion into MAC-T 
cells is in part mediated by the protein S. uberis adhesion 
molecule (SUAM) and antibodies against SUAM reduce 
the ability of S. uberis strains to adhere to and invade 
MAC-T cells in vitro [10, 29]. SUAM is highly conserved 
in S. uberis strains [30, 31], but their ability to invade 
mammary epithelial cells is variable [9, 28]. After inva-
sion, bacteria survive and possibly replicate in the epithe-
lial cells up to 120 h after challenge, with different strains 
doing this at different rates [28]. For E. coli, differences in 
invasion and intracellular survival have been linked to the 
difference between transient and persistent IMIs [32].
Like invasion of mammary epithelial cells, the role 
of biofilm formation in S. uberis mastitis has only been 
investigated in  vitro. Biofilm is a sessile form of bacte-
rial growth. Bacteria growing as biofilm are described 
as “a structured community formed by bacteria them-
selves enclosed in a self-produced polymeric matrix and 
attached to an inert or living surface” [33]. In the mam-
mary gland, this would allow the bacteria to resist host 
defences as well as the effect of antimicrobial treatment 
[34]. Differences in the ability to form biofilm have been 
found between different strains of S. aureus, with strains 
isolated from the mammary gland more capable of form-
ing biofilm in vitro than strains isolated from extra-mam-
mary sources such as teat skin and milking unit liners 
[35]. This suggests a possible role for biofilm formation 
in bacterial colonisation of the mammary gland. Ability 
to grow as biofilm has also been shown for S. uberis, with 
variation between strains but without a clear correlation 
between biofilm formation and the ability to cause clini-
cal mastitis [11, 12].
We previously conducted an intramammary challenge 
study to investigate the host response to two strains of S. 
uberis, resulting in consistent responses across cows and 
clear differences in virulence between strains, with one 
strain resulting in clinical mastitis in all cases and the 
other strain inducing no clinical disease [36]. The abil-
ity of the two strains to grow in milk of the challenged 
animals did not explain the observed difference in viru-
lence, because the non-virulent strain grew faster in milk 
than the virulent strain [36]. In the current study, we try 
to explain the difference in virulence that was observed 
in  vivo through further investigation of several putative 
virulence mechanisms in vitro, including ability to escape 
killing activity of host phagocytes, adhesion to and inva-
sion of mammary epithelial cells, biofilm formation and 
presence and composition of the sua gene.
Materials and methods
Bacteria
Two strains of S. uberis were selected to represent dif-
ferent clinical and epidemiological phenotypes as well 
as distinct genotypes. Strain FSL Z1-048 was originally 
obtained from a cow with chronic subclinical mastitis in 
mid-lactation as part of a contagious S. uberis mastitis 
outbreak. Strain FSL Z1-124, isolated around the same 
time from the same herd, was obtained from a heifer with 
transient clinical mastitis at calving and was not part of a 
mastitis outbreak [4]. Based on multilocus sequence typ-
ing, which is a standardized method for molecular typ-
ing of bacteria [37], the isolates belong to sequence type 
(ST) 385 and ST383, respectively. ST385 is part of clonal 
complex 143, which has been linked to subclinical masti-
tis, whereas ST383 differs from all known sequence types 
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by at least three alleles and does not form part of a clonal 
complex [3, 37]. In addition, the isolates are genetically 
distinct by presence or absence of a large number of open 
reading frames [38]. When used in challenge experi-
ments, FSL Z1-048 consistently induced clinical mastitis 
in challenged quarters whereas FLS Z1-124 consistently 
failed to cause clinical mastitis or even IMI [36].
Monocyte derived macrophage killing assay
The ability of bovine monocyte derived macrophages 
to kill S. uberis FSL Z1-048 and FSL Z1-124 was tested. 
Cells were obtained from 3 non-lactating Holstein heifers 
of 9–12  months of age. The experiment was conducted 
at the Moredun Research Institute (Penicuick, UK) 
with approval of the Institute’s Experiments and Ethical 
Review Committee under home office licence 60/4380 in 
accordance with the Animals (Scientific Procedures) Act 
1986.
Approximately 100  mL of blood were collected from 
the jugular vein of an individual animal and mixed imme-
diately with an equal volume of Alsever’s solution as 
anticoagulant (d-glucose 113.76  mM, sodium chloride 
71.87 mM, sodium citrate dihydrate 27.20 mM, citric acid 
2.86  mM in water). Peripheral blood mononuclear cells 
(PBMC) were isolated by layering the mixture of blood 
and anticoagulant onto Ficoll-Paque PLUS (GE health-
care, Amersham, UK) at a ratio of 2:1 and the PBMC 
layer was separated by centrifuging at 900 × g for 30 min 
at 4 °C. The PBMC layer was pipetted off and transferred 
to a new falcon tube and washed three times in com-
plete medium (RPMI-1640 supplemented with 10% vol/
vol heat inactivated FCS, 200  U/mL penicillin, 200  U/
mL streptomycin, 1% vol/vol glutamine; Sigma-Aldrich, 
Dorset, UK). Cells were finally resuspended in up to 
2 mL buffer, then labelled with mouse anti-human CD14 
microbeads (Miltenyi Biotec, Bisley, UK) and CD14+ cells 
isolated by positive selection on an LS magnetic column 
(Miltenyi Biotec) following manufacturer’s instructions. 
Viable cells were counted by trypan blue dye exclusion 
and seeded in complete medium at 1  ×  106 cells/well 
in flat-bottom 96-well polystyrene tissue culture plates 
(Corning, Tewksbury, MA, USA). Cells were cultured 
for 6 days at 37 °C, 5% CO2. Medium was changed every 
second day. 24 h before the assay, complete medium was 
replaced with complete medium without antimicrobi-
als. In preliminary experiments, purity of macrophage 
culture after the magnetic bead separation was assessed 
by flow cytometry. Briefly, 10 μL of anti-CD14 antibody 
(clone VPM65, mouse IgG1 isotype, Moredun Research 
Institute [39]) were added to 1 mL of cell suspension in 
complete medium containing 1  ×  106 cells and incu-
bated for 30 min at 4 °C. Cells were washed three times 
by centrifugation at 1500 × g for 5 min at 4  °C. 100 μL 
of goat anti-mouse IgG Alexa 488 conjugated secondary 
antibody diluted 1:2000 were added and incubated for 
30 min at 4  °C. Cells were acquired with a 2-laser Cyan 
flow cytometer (Beckman Coulter, High Wycombe, UK). 
Data were collected for a minimum of 10000 cells for 
each sample, and cells were gated based on forward and 
side scatter to exclude cellular debris from the analysis. 
Data were analysed using FlowJo software (FlowJo, Ash-
land, OR, USA). The percentage of CD14 positive cells 
was calculated. Cytocentrifuge preparations of selected 
cell samples after 7 days of culture were prepared using 
a Shandon Cytospin 4 cytocentrifuge (Thermo Electron 
Corporation, Milford, MA, USA) and stained using a 
REASTAIN Quick-Diff Kit (Reagena, Toivala, Finland) 
for microscopic examination.
To conduct the macrophage killing assays, 100  μL of 
supernatant were removed and replaced with 100 μL of 
medium containing S. uberis FSL Z1-048 or FSL Z1-124, 
which had been pre-incubated for 20 min at 37  °C with 
heat inactivated adult bovine serum (Life Technologies; 
Paisley, UK) as source of opsonins. Based on preliminary 
experiments, bacteria were diluted to have a multiplicity 
of infection (MOI) of 5 (i.e. 5 bacteria per cell). Bacteria 
and cells were co-incubated for 2 h at 37  °C in 5% CO2 
before 50 μL of 0.1% vol/vol triton X-100 (Sigma-Aldrich) 
diluted in PBS were added to lyse the cells. Cell lysates 
were tenfold serially diluted in cold PBS and 20 μL spots 
were plated in triplicate on blood agar plates (E&O Labo-
ratories, Bonnybridge, UK). Colony forming units (cfu) 
were counted, where possible for the dilution present-
ing 5–50 colonies per spot, and concentration was cal-
culated. Each result was based on the average of 3 wells 
and per strain, 3 biological replicates (i.e. blood from 3 
individual animals) and 2 technical replicates (iterations 
of the assay) were used.
PMN killing assay
To test the ability of bovine PMN to kill S. uberis, PMN 
were isolated from blood of 4 Holstein cows in mid-lac-
tation (parity 2–5). The experiment was conducted at the 
Department of Population Medicine and Diagnostic Sci-
ences, College of Veterinary Medicine, Cornell Univer-
sity (Ithaca, NY, USA) using animals held by the Cornell 
Teaching and Research Facility (Ithaca, NY, USA). All 
procedures were approved by the Cornell Institutional 
Animal Care and Use Committee.
Approximately 20 mL of blood were collected from the 
jugular vein of individual animals in vacutainer vials con-
taining heparin as anti-coagulant. Blood was processed 
within 1  h of collection. It was diluted with an equal 
volume of PBS and the mixture was layered on Ficoll-
Paque plus (GE Healthcare) and centrifuged for 30 min 
at 900 × g at 4 °C. The granulocyte layer was transferred 
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to a fresh 50 mL falcon tube. Residual erythrocytes were 
lysed by adding 5 mL of pre-warmed lysis solution (0.8% 
wt/vol NH4Cl, 0.1 mM EDTA in water, 37 °C). Cell sus-
pensions were gently mixed until the erythrocytes were 
completely lysed. 20  mL of PBS were added, then cells 
were washed twice by spinning at 300 × g for 10 min at 
4  °C and finally resuspended in RPMI-1640 (Life Tech-
nologies) supplemented with 10% heat inactivated fetal 
calf serum (FCS) and 4  mM glutamine. Viable cells 
were microscopically counted based on trypan exclu-
sion staining. Cells were seeded in 96-well polystyrene 
cell culture plates (Corning) at 5  ×  105 cells per well 
in a total volume of 200  μL. After pre-incubation for 
20 min at 37 °C with heat inactivated adult bovine serum 
(Life Technologies) as source of opsonins, S. uberis FSL 
Z1-048 or FSL Z1-124 was added to wells at MOI of 1 
with PMN. Bacteria and PMN were co-incubated for 
90 min at 37 °C, 5% CO2. To lyse the cells, 50 μL of 0.1% 
vol/vol triton X-100 (Sigma-Aldrich) diluted in PBS were 
added. Cell lysates were tenfold serially diluted in cold 
PBS and 20 μL spots were plated in triplicate on blood 
agar plates (BioMerieux Inc. Durham, NC, USA). Cfu 
were counted, where possible for the dilution present-
ing 5–50 colonies per spot, and concentration was cal-
culated. In preliminary experiments, purity of the cell 
population after isolation of PMN was tested with flow 
cytometry analysis. Cells were stained with antibodies 
against CD11b (Monoclonal FITC conjugated, Mouse 
IgG2b, VMRD Inc., Pullman, WA, USA) and anti CD14 
(Monoclonal APC conjugated Mouse IgG1, VMRD Inc.) 
antigens using a protocol described by Schwarz et  al. 
[16]. Each result was based on the average of 3 wells and 
per strain, 4 biological replicates (i.e. blood from 4 indi-
vidual animals) were used.
Mammary epithelial cell adhesion and invasion assay
In mammary epithelial cell invasion assays, Salmonella 
enterica serovar Typhimurium strain 12023 was included 
as positive control [40] (kindly provided by Professor 
David GE Smith, Moredun Research Institute), whilst E. 
coli laboratory strain TOP10 (Invitrogen, Paisley, UK) 
was included as negative control for the invasion assay. 
Streptococcus uberis strains were grown in brain heart 
infusion broth (BHI; Oxoid, Basingstoke, UK) for 18  h 
at 37  °C under shaking (200  rpm) whereas the positive 
and negative control strains were grown in Lysogeny 
broth (BD, Oxford, UK) for 18  h at 37  °C under shak-
ing (200 rpm). Bacterial suspensions were centrifuged at 
4000 × g for 20 min at 4 °C, washed three times in cold 
PBS, and finally resuspended in PBS. Concentrations of 
live bacteria were determined by viable count method 
[36]. Suspensions were diluted to the target concentra-
tions and stored at 4 °C prior to use.
Immortalized bovine mammary epithelial cell line 
BME-UV1 cells [41] were cultured at 37 °C under 5% CO2 
in 75 cm2 tissue culture flasks (Corning). BME-UV1 com-
plete medium consisted of a mix containing 40% Ham’s 
F-12 nutrient mixture, 30% RPMI-1640 medium and 20% 
NCTC 135 medium. All media were obtained from Life 
Technologies. The medium was supplemented with 10% 
(wt/vol) heat inactivated FCS, 0.1% (wt/vol) lactose, 0.1% 
(wt/vol) lactalbumin hydrolysate, 1.2  mM glutathione, 
10 μg/mL l-ascorbic acid, 1 μg/mL hydrocortisone, 1 μg/
mL insulin, 200 U/mL penicillin and 200 U/mL strepto-
mycin. All reagents were obtained from Sigma-Aldrich. 
Cells were cultured until 70–80% confluency, as judged 
visually by light microscopy, and then washed with warm 
PBS and treated with 1  mL of TrypLE Express disso-
ciation media (Life Technologies) supplemented with 
4  U/mL of porcine elastase (Sigma-Aldrich) and incu-
bated at 37  °C until 70–80% of the cells were showing a 
shrunken morphology. Medium was then discarded and 
1  mL of TrypLE Express dissociation medium per flask 
was added. Flasks were incubated until the cells were 
completely detached from the plastic surface. Complete 
medium was added and cells transferred to a new flask. 
Cells from passage 5–10 were transferred to 24-well tis-
sue culture plates (Corning) at 1  ×  105 cells/well and 
cultured for 1 day in complete medium. Medium was dis-
carded and cells were rinsed three times with warm PBS. 
The cells were then cultured in antibiotic free medium 
for 18 h until the assay was performed.
Bacterial challenge preparations were added to the 
supernatant of the completely confluent monolayer of 
BME-UV1 cells (approximately 1 × 106 cells/well). Strep-
tococcus uberis FSL Z1-048 or FSL Z1-124 was added to 
obtain a final concentration of 1 × 107 and 1 × 108 cfu/
mL in the culture media, representing multiplicity of 
infection (MOI) of 10 and 100 (bacteria:epithelial cell 
ratio) respectively. Positive and negative controls were 
added at approximately MOI of 1. Cells and bacteria 
were co-incubated for 3  h at 37  °C under 5% CO2. Cell 
culture supernatants were discarded and wells were vig-
orously washed three times with warm PBS to eliminate 
non-adherent bacteria. Cells were lysed by adding 500 μL 
per well of 0.1% vol/vol Triton X-100 (Sigma-Aldrich) 
diluted in PBS. Lysates were serially diluted in cold PBS 
and 20 μL spots of the serial dilutions were plated in trip-
licate on blood agar plates (E&O Laboratories). Plates 
were incubated overnight at 37 °C, colonies were counted 
and the concentration of bacteria (cfu/mL) associated 
with the cells (adhered to the surface and internalized) 
was calculated. In parallel assays, performed on separate 
plates, washed cells were incubated for 1 h at 37  °C, 5% 
CO2 with 1 mL per well of growth medium supplemented 
with 150  μg/mL gentamicin to kill the extracellular 
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bacteria so that internalization but not adherence was 
measured. Cells were washed 3 times with warm PBS 
and lysed by adding 500 μL per well of 0.1% vol/vol Tri-
ton X-100 (Sigma-Aldrich) diluted in PBS. Lysates were 
serially diluted in cold PBS and 20 μL spots of the serial 
dilutions were plated in triplicate on blood agar plates 
(E&O Laboratories). Plates were incubated overnight at 
37  °C, colonies were counted and the concentration of 
bacteria (cfu/mL) internalized in the cells was calculated. 
The number of bacteria that adhered on the surface was 
obtained by subtracting the concentration of internalized 
bacteria from the total concentration of bacteria associ-
ated with the cells [28]. The experiment was conducted 
three times, with the results for each strain based on the 
average of three wells in each replicate.
Biofilm assay
The ability to form biofilm was assessed using FSL 
Z1-048, FSL Z1-124 and a positive control (S. uberis 
strain 20539) in a protocol described by Gilchrist [42] 
with some modifications. Streptococcus uberis strains 
were cultured in BHI for 16  h at 37  °C under shak-
ing (150  rpm). BHI culture was diluted 100-fold in 
one of three different media: (1) BME-UV1 complete 
medium, (2) BME-UV1 complete medium supplemented 
with 0.5% wt/vol casein, and (3) RPMI-1640 chemi-
cally defined medium (CDM) supplemented with 0.5% 
casein. RPMI-1640 CDM was composed of RPMI-1640 
(Sigma-Aldrich) supplemented with 0.8% wt/vol lac-
tose, 260  mg/L l-glutamic acid, 150  mg/L magnesium 
sulphate heptahydrate, 10  mg/L ferrous sulphate hep-
tahydrate, 10  mg/L manganese sulphate tetrahydrate. 
All reagents were obtained from Sigma-Aldrich. Two 
hundred μL per well of inoculated media were aliquoted 
into 96-well flat bottom polystyrene tissue culture plates 
(Corning). Plates were incubated statically at 37  °C in 
5% CO2 for 24 h. Medium was discarded and wells were 
washed three times with distilled water to remove cells 
not adhered to the plate. Plates were air dried for 45 min 
and biofilms were stained by adding 100  μL/well of 1% 
crystal violet solution (Fisher Scientific, Loughborough, 
UK). Stain was discarded and wells washed with distilled 
water until excess stain was completely removed. Plates 
were air dried for 45 min, followed by addition of 200 μL/
well of ethanol and incubation for 15 min. Optical den-
sity (OD) at 562  nm was read with an ELx808 absorb-
ance microplate reader (Biotek instruments, Potton, UK) 
to quantify biofilm formation. Sample to positive (S/P) 
ratio for each strain was calculated by dividing the dif-
ference between average OD for that strain and average 
negative control OD by the difference between the aver-
age positive control OD and average negative control OD. 
For RPMI-1640 CDM supplemented with 0.5% casein, 3 
biological replicates were performed whereas the biofilm 
formation in BME-UV1 complete medium and BME-
UV1 complete medium with 0.5% casein was tested 
once based on results from the first round of assays (see 
Results). The experiment was conducted three times, 
with results based on the average of eight wells per strain 
in each replicate.
Sua sequencing
The 2970  bp nucleotide sequence of the sua gene 
was amplified using the forward primer LfbpDL5 
5′-GTCATTTGGTAGGAGTGGCTG-3′ and the reverse 
primer LfbpDL6 5′-TGGTTGATATAGCACTTGGT-
GAC-3 [30] which provide full length amplification of 
the gene. PCR was conducted in a final volume of 100 μL 
containing 50 μL of GoTaq Green master mix (Promega, 
Madison, WI, USA), 50 μL of water, 300 nM of primers 
LfbpDL5 and LfbpDL6 and 100  ng of genomic DNA as 
template. The cycling profile consisted of 94 °C for 2 min 
followed by 30 cycles of 30 s at 94 °C, 30 s at 54 °C, and 
2  min at 68  °C followed by 7  min at 68  °C. PCR prod-
uct (15 μL) was visualized on a 1% agarose gel. The PCR 
products were purified using wizard SV gel and PCR 
clean-up system (Promega, Southampton, UK). Two 
15 μL aliquots of the purified PCR products were sent to 
Eurofins Genetic Services (London, UK) for bidirectional 
sequencing using the following forward primers: Lfb-
pDL5, 5′-TCAAATGCCTC-3′, 5′-CCGTATCGTTAAC-
CCAGA-3′ and 5′-CGCTTGTTCACCTAA ATCAG-3′. 
The following primers were used in the reverse direction: 
LfbpDL6, 5′-CGCTTCTTGAGCAGTATCTACTG-3′, 
5′-GACTGATTTAGGTGAACAAGCG-3′ and 
5′-CTGGGTTAACGATACGG-3′ [30]. Sequence reads 
were aligned, checked for quality of the electophero-
gram and analysed using the SeqMan program within the 
Lasergene 11 package (DNASTAR, WI, USA). Sua nucle-
otide sequences were aligned with the reference sequence 
of strain UT888 (GenBank: DQ232760.1). The nucleotide 
sequence of sua was further analysed using sequence 
manipulation suite ORF finder [43] to assess the presence 
of stop codons and determine the translated amino acid 
sequences, and submitted to the European Nucleotide 
Archive.
Statistical analysis
Statistical analyses were conducted in Genstat (VSN 
International, Hemel Hempstead, UK). For all statistical 
analyses, significance was declared when p  <  0.05. For 
macrophage and PMN killing assays, percentage bacterial 
survival was calculated as the proportion of viable bac-
teria in wells with phagocytes compared to control wells 
containing bacteria and growth medium only. Percent-
age survival was compared between strains using a t test. 
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Adhesion and invasion data, expressed as concentration 
of bacteria that invaded cells and concentration of bac-
teria that adhered to the cells, respectively, were base-10 
logarithmically transformed to ensure the data from each 
treatment group had an approximately normal distribu-
tion. The log-transformed concentrations were used as 
outcome variable in a two-way ANOVA with strain and 
MOI as treatment factor. Replicate number was used as 
blocking factor. The interaction between strain and MOI 
was also evaluated. Normality of the distribution of the 
residuals was assessed using Q–Q probability charts with 
95% confidence limits and by the Anderson–Darling 
marginal test. Homogeneity of variance of the residu-
als was assessed by Bartlett’s test. Post-hoc comparisons 
with Tukey HSD test were performed where appropriate. 
Results from the biofilm experiments were not normally 
distributed and results were analysed by non-parametric 
Mann–Whitney test, using S/P as input to correct for 
potential plate-to-plate variability.
Results
Macrophage killing assay
The ability of macrophages derived from blood mono-
cytes to kill S. uberis FSL Z1-048 and FSL Z1-124 was 
tested. Flow cytometry results from preliminary experi-
ments showed that, after purification from blood, 
approximately 90% of cells were CD14+ (results not 
shown). After 7  days of culture, approximately 95% of 
cells showed the morphology of differentiated mac-
rophages at microscopic examination. Bactericidal abil-
ity of monocyte-derived macrophages was significantly 
different between the two strains (p < 0.001). Monocyte-
derived macrophages were able to kill strain FSL Z1-124. 
The proportion of viable bacteria present after 2 h of co-
incubation with host cells was 58 ± 22% of the bacteria 
incubated in the medium only (Figure  1A). In contrast, 
macrophages failed to kill strain FSL Z1-048. Bacteria 
recovered after 2 h were 124 ± 33% of the bacteria incu-
bated in the medium only, suggesting a replication in 
presence of macrophages (Figure 1A).
PMN killing assay
Flow cytometry analysis showed that, after the PMN iso-
lation process, approximately 75% of cells were CD11b+ 
CD14− and thus likely to be PMN. This proportion was 
confirmed by microscopic observation of morphology of 
cells present in the cell preparations. PMN from bovine 
blood were able to kill both S. uberis strains (Figure 1B). 
Bactericidal ability of PMN was significantly different 
between the two strains (p = 0.014), with higher bacte-
ricidal activity observed against strain FSL Z1-048. Per-
centage survival for strain FSL Z1-048 was 33  ±  10% 
whereas for strain FSL Z1-124 it was 56 ± 19%.
Adhesion and invasion assay
Both S. uberis strains were able to adhere to the bovine 
mammary epithelial cell line BME-UV1 after 3  h of co-
incubation. FSL Z1-048 showed 1000-fold higher levels 
of adherence than strain FSL Z1-124 at MOI 10 and 100 
(p < 0.05) (Figure 2). For both strains, adherence increased 
approximately 15-fold at MOI 100 compared to MOI 10, 
but the difference in adherence between MOIs was signif-
icant only for strain FSL Z1-048 (p < 0.05) (Figure 2).
Both strains were able to invade epithelial cells after 
3 h of co-incubation (Figure 3). FSL Z1-124 was 37-fold 
as invasive as strain FSL Z1-048 at MOI 10 (p  <  0.05) 
Figure 1 Uptake and killing of Streptococcus uberis by host phagocytes. A Killing of S. uberis strains FSL Z1-048 and FSL Z1-124 by bovine 
monocyte derived macrophages. Data represent the percentage (±standard deviation) of bacteria that survived after 2 h of co-incubation with 
macrophages. Data were obtained using cells isolated from blood of 3 animals, tested individually, and the experiment was conducted twice. The 
p value for the t test is shown, calculated using 6 observations per strain with each observation based on the average of 3 wells. B Killing of S. uberis 
strains FSL Z1-048 and FSL Z1-124 by bovine polymorphonuclear cells (PMN). Data represent the percentage (±standard deviation) of bacteria that 
survived after 1.5 h of co-incubation with PMN. Data were obtained in one experiment using PMN from 4 animals, tested individually. The p value 
for the t test is shown, calculated using 4 observations per strain, with each observation based on the average of 3 wells.
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whereas at MOI 100, invasion was not significantly dif-
ferent between strains. Bacterial concentration had an 
effect on internalization of strain FSL Z1-048, which was 
63-fold as invasive at MOI 100 as at MOI 10 (p < 0.05), 
whereas for strain FSL Z1-124, internalization at MOI 
100 was not significantly different to that observed at 
MOI 10 (Figure 3). The positive control included in the 
invasion assay, S. enterica serovar Typhimurium, was able 
to adhere to (Figure 2) and to invade (Figure 3) the mam-
mary epithelial cells in all assays. The negative control E. 
coli laboratory strain was not able to invade the cells in 
any assay (data not shown).
Biofilm assay
Ability to form biofilm when grown in RPMI-1640 CDM 
supplemented with 0.5% casein differed between strains. 
The ability of FSL Z1-048 to form biofilm was signifi-
cantly lower (p < 0.05; Figure 4) than the ability of strain 
FSL Z1-124. In preliminary experiments, ability to form 
biofilm was also tested in BME-UV1 complete medium 
and BME-UV1 complete medium supplemented with 
casein but none of the strains were able to form biofilm in 
these media (results not shown).
Sua sequence
Analysis of open reading frames (ORF) in the full length 
2971  bp sua gene showed that strain FSL Z1-124 has 
an ORF extending from base 94 to base 2811 with 99% 
DNA sequence identity to the ORF from strain UT888 
(2939/2971  bp; NCBI Accession number DQ232760.1). 
The sua sequence [European Nucleotide Archive: 
LN885239] translates into a protein of 905 amino acids 
in length (Figure 5), which is the full length of the SUAM 
protein [29]. The protein sequence showed 98% identity 
with the SUAM protein from strain UT888 (884/905 
amino acids). Identity of the sua sequence of strain 
FSL Z1-048 with sua of S. uberis strain UT888 was 99% 
(2955/2971), with a one-base pair gap causing a frame-
shift mutation in position 700 (5′→3′) of the submitted 
sequence (European Nucleotide Archive: LN885238). 
The nucleotide base missing in sua of strain FSL Z1-048 
resulted in an ORF extending from base 94 to base 744 
that would be translated in a truncated SUAM protein 
of 216 amino acids in length (Figure  5). The sequence 
encoding pep-SUAM [10] was intact in both strains 
and the predicted amino acid sequence for FSL Z1-048 
was identical to that of UT888, whilst the amino acid 
sequence for FSL Z1-124 differed by one amino acid.
Discussion
Different strains of S. uberis are associated with differ-
ent clinical and epidemiological phenotypes [4, 36]. In 
the present study, we compared a clinically virulent, 
Figure 2 Adhesion of Streptococcus uberis to bovine mammary 
epithelial cells BME-UV1 in vitro. Cells were incubated with strain 
FSL Z1-048 or strain FSL Z1-124 at 1 × 107 cfu/mL and 1 × 108, to 
obtain a multiplicity of infection (ratio bacteria:cells) of 10 (white col-
umns) and 100 (striped columns), respectively. Results are expressed 
as concentration of bacteria recovered after 3 h of co-incubation. The 
values represent the mean and the standard deviation of 3 replicates, 
with each replicate based on the average of 3 wells. The solid grey 
bar represents the concentration of Salmonella enterica serovar Typh-
imurium strain 12023 used as positive control. Replicate number was 
used as blocking factor. Statistically significant and non-significant 
differences between groups are marked with asterisks and NS respec-
tively (Tukey HSD test after ANOVA, *p < 0.05).
Figure 3 Invasion of Streptococcus uberis into bovine mam-
mary epithelial cells BME-UV1 in vitro. Cells were incubated 
with strain FSL Z1-048 or strain FSL Z1-124 at 1 × 107 cfu/mL and 
1 × 108, to obtain a multiplicity of infection (ratio bacteria:cells) of 
10 (white columns) and 100 (striped columns) respectively. Results 
are expressed as concentration of bacteria internalized after 3 h of 
co-incubation. The values represent the mean and the standard 
deviation of 3 replicates, with each replicate based on the average of 
3 wells. The solid grey bar represents the concentration of Salmonella 
enterica serovar Thypimurium strain 12023 used as positive control. 
Statistically significant and non-significant differences between 
groups are marked with asterisks and NS respectively, with replicate 
used as blocking factor (Tukey HSD test after ANOVA, *p < 0.05).
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putatively host-adapted outbreak strain with a non-vir-
ulent, opportunistic non-outbreak strain with regards 
to characteristics that are thought to be associated with 
virulence, i.e. evasion of host phagocytes, interaction 
with mammary epithelial cells, biofilm formation and the 
sua gene. Previously, the ability of the two strains to grow 
in milk had been evaluated [36]. For 5 of 7 hypotheti-
cal virulence characteristics, our observations did not 
match expectations, i.e. the strain that was non-virulent 
in  vivo displayed the more virulent phenotype or geno-
type in vitro (Table 1). The strain that was virulent in vivo 
had a more virulent phenotype in vitro only for evasion 
of macrophage killing and adhesion to mammary epithe-
lial cells. This direct comparison of strains with clearly 
described clinical and epidemiological phenotypes casts 
doubt on the biological importance of some supposed 
virulence traits, including presence of an intact sua gene. 
Although the heterogeneity of the S. uberis population 
necessitates further studies to determine whether these 
observations extend to other strains, these result indi-
cate which traits may deserve to be prioritised in further 
research into the pathogenesis and control of S. uberis 
mastitis. It is also possible that different strains use differ-
ent combinations of virulence traits, and that there is no 
single mechanism explaining virulence, as recently sug-
gested based on genomic studies [44].
Macrophages are one of the most common cell popu-
lations in the healthy lactating mammary gland and 
are thought to be the first defence in case of infection 
[14, 15]. In our study, bovine macrophages were able 
to kill the non-virulent S. uberis strain in  vitro whereas 
they were not able to kill the virulent strain. If in  vitro 
results are representative of macrophage activity in vivo, 
resident macrophages may be able to clear the non-vir-
ulent bacteria before infection becomes established. Con-
versely, virulent strain FSL Z1-048 would not be cleared 
by macrophages and thus bacteria would be able to rep-
licate within the mammary gland. Failure to kill S. uberis 
by bovine milk macrophages was similarly observed in a 
previous study of the clinically virulent strain O140 J [18]. 
Although different methods were used in the different 
studies, the results suggest that the ability to resist killing 
by macrophages may play a role in the pathogenicity of S. 
uberis. Results from our challenge study showed that dif-
ferences in pathogenesis exist very early in the infection 
process [36]. Within 18 h after challenge, a pronounced 
difference in bacterial numbers was seen between the 
virulent strain and the non-virulent strain, whilst dif-
ferences were not observed yet in clinical parameters, 
somatic cell count or cytokine levels at that time. This 
difference in abundance in the first 18 h after challenge 
was not explained by the ability of the strains to grow in 
milk, with the non-virulent strain growing faster in the 
challenge cows’ milk in  vitro than the virulent strain 
[36]. Thus, the in vitro and in vivo data support the idea 
that resident macrophages, as the first line of defence in 
the mammary gland, are at least in part responsible for 
strain-specific results early after intramammary chal-
lenge with S. uberis.
In vitro, bovine PMN were able to kill both FSL Z1-048 
and FSL Z1-124. Surprisingly, the virulent strain was 
killed more easily than the non-virulent strain. This result 
is in contrast to that obtained by Hill, who observed 
that the ability to resist PMN killing was related with 
the virulence of the strain when infused into the lactat-
ing mammary gland [23]. PMN are present in relatively 
low numbers in the healthy mammary gland and they are 
recruited in large numbers from the blood stream fol-
lowing an inflammatory stimulus [19]. This was observed 
in our challenge study at 30–42  h post-challenge. By 
that time, bacterial numbers and clinical outcome were 
already vastly different between strains, so strain-specific 
virulence during onset of infection was not driven by the 
interaction with PMNs. PMN may, however, play a role 
Figure 4 Biofilm formation of Streptococcus uberis strains FSL 
Z1-048 and FSL Z1-124. Biofilm formation was tested in RPMI-1640 
CDM medium supplemented with 0.5% wt/vol casein. Strain 20539 
was included as positive control (+ve). Bars represent the sample-
to-positive (S/P) ratio after 24 h of culture and standard deviations. 
S/P = (average sample OD − average negative control OD)/(aver-
age positive control OD − average negative control OD), where 
OD = optical density. The assay was conducted on 3 cultures of each 
strain and for each assay the result was based on the average of 8 
wells. Statistically significant difference between the two strains is 
marked with asterisk (Mann–Whitney test, *p < 0.05).
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in the resolution of infection as massive influx of PMN 
coincided with the onset of a 10000-fold reduction in cfu 
count [36]. At that time, levels of various cytokines were 
also significantly increased compared to baseline levels, 
which may enhance the ability of PMN to kill bacteria 
in vivo.
UT888           MSRTIKSSLKLGIFLTIYNVWREKGNIMELENTKSNQIKTTLALTSTLALLGTGVGMGHTVNADDMTTADQSPKLQGEEA 80
FSL_Z1-124      ***************M*C*******I***F************************************K************* 80
FSL_Z1-048      *****************************F************************************************** 80
UT888           TLAPTNIEDTKAAIDTKTATLAEQTDALNTVNETITSTNEELATLEGGLADKETAVADAEKTLESVSNASEEEFNQLAEQ 160
FSL_Z1-124      **********R**************N****************************************************** 160
FSL_Z1-048      **********K****I**************************************************************** 160
UT888           NKADLAKTQEELKLAEATKEEVATQVLTQSDEVTAAANEAKKMAEKVAQAETKVSDLTKMVNQPEAITAQVEIEQNNVKI 240
FSL_Z1-124      ******************************************************L************************* 240
FSL_Z1-048      ******************************************WLK*LHKQRQKFQT------------------------ 216
UT888           ISEDLAKAKTDLVAVTDNTKTQLANDLATAQSSLSAKQNELAKVQSQTSNVAVNVMGANKMVAPTNYPINEIKKLMSSGY 320
FSL_Z1-124      ******************************************************************************** 320
FSL_Z1-048      --------------------------------------------------------------------------------
UT888           IGTQSYLNTFYALKDQLVSKAEVGAYLNHYVDIASDLNRIVNPDNLSVEVQNELAVFAATLINSVRQQFGLSAVEVTQGA 400
FSL_Z1-124      *********************K********************************************************** 400
FSL_Z1-048      --------------------------------------------------------------------------------
UT888           QEFARTLTQNYKATHGNTVPFFNYNQPGKNGHIGIGPHDRTIIEQAATSVGLKANDDNMYENIGFFDDVHTVNGIKRSIY 480
FSL_Z1-124      *********************************T********************************************** 480
FSL_Z1-048      --------------------------------------------------------------------------------
UT888           NSIKYMLFTDLTYGNTFGHTVNLLRSDKTNPSAPVYLGVSTETVGGLNTHYVIFPASNIVNASQFSKQVVSGPLTTVDNS 560
FSL_Z1-124      **********F*************************************************K******************* 560
FSL_Z1-048      --------------------------------------------------------------------------------
UT888  AKISTLQASIASVESKIQTLQKRIANISSEALVISAQRKVDGLAAKLQKAESNVEKAKAQLQQLKDSKEDLHKQLAFALS 640
FSL_Z1-124      ****************************************************************Q*************** 640
FSL_Z1-048      --------------------------------------------------------------------------------
UT888           TRKDLKGQLDESLVHLNQSKILFHSLEEKQSQVASQINVLTLKKAQLEKELAFNSHPNREKVAKEKVEEAQKALTETLSQ 720
FSL_Z1-124      **********************L********************************************************* 720
FSL_Z1-048      --------------------------------------------------------------------------------
UT888           IKTKKAILNDLTQEKAKLTSAITTTEQQIVLLKNHLANQVANAPKISSIVQRSENNGVRPDVSDTREKAVDTAQEATILA 800
FSL_Z1-124      ***********************************************N****L***R*********************** 800
FSL_Z1-048      --------------------------------------------------------------------------------
UT888           QAETMAEEVITNSAKAIVANAQNVAQEIMKVAPEVTPDQGVVAKVADNIKKNNAPASKSYGASSSTVGNATSSRDESTKR 880
FSL_Z1-124      ******************************************************************************** 880
FSL_Z1-048      --------------------------------------------------------------------------------
UT888           ALRAGIVMLAAAGLTGYKLRRDGKK 905
FSL_Z1-124      ************************* 905
FSL_Z1-048      -------------------------
II III
IV
V
I
Figure 5 Alignment of amino-acid sequences of Streptococcus uberis adhesion molecule (SUAM). Alignment based on translation of sua 
sequences for strains FSL Z1-124, FSL Z1-048, and UT888, showing the five functional domains identified in UT888 (I–V) [28]. Due to a frameshift 
mutation, the predicted protein of strain FSL Z1-048 is truncated although pep-SUAM is predicted to be intact.
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Adhesion to and invasion of epithelial cells of the mam-
mary gland have been suggested to be a crucial step in 
development of IMI by S. uberis [9, 28]. In vitro, both 
strains tested in our study were able to adhere to UV-
BME cells after 3  h of co-incubation. Adherence was 
affected by MOI, but at both MOI levels tested, the viru-
lent strain had a higher ability to adhere to mammary epi-
thelial cells than the non-virulent strain. In the challenge 
study, cows were first milked at 9 h post challenge. Based 
on growth assays in milk of the challenge cows, bacterial 
concentrations at 9  h post inoculation were higher for 
the non-virulent strain than for the virulent strain [36]. 
If, however, the non-virulent strain did not adhere well 
to epithelial cells, most of the bacteria may have been 
removed at milking. Conversely, the virulent bacteria, 
although potentially lower in number based on growth 
assays, may have adhered and persisted in the mammary 
gland during milking. Together with killing of the non-
virulent strain by macrophages, the difference in adher-
ence may help to explain why cfu counts were so different 
between the two strains during experimental challenge 
even before PMN influx, clinical signs or cytokines were 
observed. These results also suggest that key early events 
during colonisation had the largest impact on the subse-
quent pathogenicity of the two strains.
Both strains were able to invade mammary epithelial 
cells but the non-virulent strain, FSL Z1-124, showed 
more invasion at lower MOI. The ability of FSL Z1-124 
to invade epithelium did not change with MOI, whereas 
the invasive ability of FSL Z1-048 was greater at higher 
MOI. An increase in bacterial concentration, as observed 
in  vivo [36], could increase the ability of this strain to 
invade the mammary epithelium after the initial stage 
of the infection. Internalization in mammary epithelial 
cells would protect the pathogen from phagocytes in the 
mammary gland. In could also provide protection against 
antimicrobials used in the therapy of IMI, although some 
antimicrobials penetrate intracellularly and are effective 
in the intracellular environment [45]. Invasion of mam-
mary gland cells by S. uberis has been observed in vitro 
but not in challenge studies and its role in vivo remains to 
be confirmed [17, 26]. In vivo, FSL Z1-124 was rarely and 
intermittently isolated from challenged quarters, mostly 
from 12 to 48  h post challenge [36]. In one cow, it was 
detected in milk at 168 h post challenge, with no positive 
culture results between 48 and 168 h (unpublished data). 
Strain identity was confirmed using PFGE [36] to ensure 
that the positive culture at 168 h was not due to a differ-
ent strain. The observation of intermittent shedding of 
FLS Z1-124 could potentially be explained by intracellu-
lar survival. Based on our observations, we would like to 
propose the following hypothetical scenario: after chal-
lenge, FSL Z1-124 grows rapidly in milk but it is elimi-
nated by macrophages and, due to its poor adherence to 
epithelial cells, also by milking. When FSL Z1-124 does 
adhere, this is followed by rapid invasion into the mam-
mary epithelial cell, where it may survive for several days, 
as described for other strains in  vitro [28], explaining 
intermittent shedding. FSL Z1-124 was originally isolated 
from a heifer at calving, demonstrating that it has the 
ability to cause mastitis, but possibly only during immu-
nosuppression of the host, such as occurs around partu-
rition [46].
In previous studies conducted in vitro, internalization 
was shown to be partially mediated by S. uberis adhe-
sion molecule (SUAM), with deletion of sua reducing the 
ability of S. uberis to adhere to and internalize in mam-
mary epithelial cells [47]. The gene encoding SUAM is 
conserved in strains of S. uberis from different geographi-
cal locations [30]. Analysis of the full genome sequence 
of our study isolates showed the presence of sua in both 
strains and suggested the existence of a frame-shift muta-
tion in sua of FSL Z1-048 (data not shown). PCR and 
Sanger sequencing, as reported here, confirmed that the 
sua gene in FSL Z1-124 would code for a protein of 905 
amino acids in length as described by Luther et  al. [30] 
whereas sua in FSL Z1-048 is predicted to code for a 
truncated protein of 216 amino acids. Antibodies against 
pep-SUAM reduce adherence of S. uberis to MAC-T 
cells, demonstrating a role of pep-SUAM in adhesion 
in vitro [10]. pep-SUAM is predicted to be expressed by 
FSL Z1-048 and may be functionally active. However, 4 
other predicted epitopes thought to be involved in the 
process of adhesion and invasion mediated by SUAM 
are located between amino acid residues 342 and 719 
[48] and not expressed in FSL Z1-048. Despite this, 
FSL Z1-048 demonstrated high levels of adherence to 
Table 1 Overview of  potential virulence characteris-
tics of  Streptococcus uberis and  their in  vitro manifesta-
tion in  FSL Z1-048 and  FSL Z1-124, which were virulent 
and  non-virulent, respectively, in  experimental challenge 
studies [36]
a Based on Tassi et al. [36]
b ↑ Means that the trait as observed in vitro would be expected to increase 
virulence in vivo compared to the other strain and ↓ means that the trait as 
observed in vitro would be expected to decrease virulence in vivo.
Virulence trait FSL Z1-048 FSL Z1-124
Growth in milka ↓b ↑
Resistance to macrophage killing ↑ ↓
Resistance to PMN killing ↓ ↑
Adhesion ↑ ↓
Invasion ↓ ↑
Biofilm formation ↓ ↑
Sua ↓ ↑
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UV-BME cells. Recent studies suggest that SUAM is not 
the only adhesin involved in the adhesion and invasion 
of mammary epithelial cells as deletion of sua reduced 
but did not eliminate the ability of S. uberis to adhere to 
and invade MAC-T cells in vitro [47]. In addition, assays 
with random mutants revealed that other adhesins could 
be involved in the adhesion and invasion process [49]. 
Therefore, adherence and invasion of strain FSL Z1-048 
to the mammary epithelium is likely to be mediated by 
other, as yet unidentified, SUAM-independent mecha-
nisms. Adherence and invasion were MOI-dependent for 
FSL Z1-048 but not for FSL Z1-124, suggesting that the 
underlying mechanism differs between the two strains. 
For E. coli¸ as for S. uberis, adherence and invasion dif-
fer between strains, with some strains showing MOI-
dependent invasion into mammary epithelial cells whilst 
others do not [50, 51].
In the current study, the virulent S. uberis strain 
showed poor biofilm formation whereas the non-virulent 
strain did form biofilm. The results of the biofilm assay 
depended strongly on the culture conditions, as exem-
plified by the lack of biofilm formation in BME-UV1 
medium. This implies that observations in the adherence 
and invasion assays, which were conducted in BME-UV1 
medium, will not have been skewed by differences in bio-
film formation. Addition of casein, which is thought to be 
a major inducer of biofilm formation [12], did not affect 
growth in RPMI-1640 CDM. Differences in biofilm for-
mation under different conditions have previously been 
described for the reference strain O140J, which showed 
good biofilm formation in one study and poor biofilm 
formation in another [11, 12]. It is largely unknown 
which in vitro conditions would be an appropriate or rel-
evant reflection of in vivo conditions with regards to bio-
film formation.
In summary, using two clinically and epidemiologically 
well-characterised strains of S. uberis, we demonstrated 
strain-dependent differences in the resistance against 
macrophage killing, which may play an important role 
in the early pathogenesis of IMI. Additionally or alter-
natively, adhesion to the mammary epithelial cells may 
help to determine the outcome of intramammary chal-
lenge. Thus, these virulence factors represent attractive 
targets for further research into pathogenesis and control 
of S. uberis mastitis. An intact sua gene does not appear 
necessary for adherence. Growth in milk, phagocytosis 
by PMN, ability to invade the mammary epithelial cells 
and biofilm formation in vitro were not associated with 
virulence differences in vivo although PMN do appear to 
make an important contribution to elimination of infec-
tion. Given the heterogeneity of the S. uberis population, 
further work is required to determine whether these 
observations extend to other strains.
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